Key Studies in Metastatic Breast Cancer From ASCO 2020 Key Studies in Metastatic Breast Cancer From ASCO 2020

Key studies in metastatic breast cancer from ASCO 2020 focus on first-line checkpoint inhibition in TNBC; also, updated evidence that tucatinib plus chemotherapy benefits women with HER2+ disease.Medscape

Source: Medscape Today Headlines - June 22, 2020 Category: Consumer Health News Tags: None ReCAP Source Type: news